BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22261456)

  • 1. Degenerative necrotic endometrial debris in Papanicolaou smears. The role in the prediction of endometrial pathology.
    Lai CR; Hsu CY; Li AF
    Am J Clin Pathol; 2012 Feb; 137(2):290-4. PubMed ID: 22261456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.
    Chang A; Sandweiss L; Bose S
    Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cells and the AutoPap System for primary screening of cervicovaginal Pap smears.
    Walts AE; Thomas P
    Diagn Cytopathol; 2002 Oct; 27(4):232-7. PubMed ID: 12357502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective.
    Kapali M; Agaram NP; Dabbs D; Kanbour A; White S; Austin RM
    Cancer; 2007 Feb; 111(1):26-33. PubMed ID: 17262796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas.
    Moatamed NA; Le LT; Levin MR; Govind R; Apple SK
    Diagn Cytopathol; 2013 Apr; 41(4):335-41. PubMed ID: 22102567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
    Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
    Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.
    Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE
    Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic Value of Routine Papanicolaou Smears for Detecting Endometrial Cancers: An Update.
    Lai CR; Hsu CY; Hang JF; Li AF
    Acta Cytol; 2015; 59(4):315-8. PubMed ID: 26315394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of benign endometrial cells in Pap smears from postmenopausal women.
    Wu HH; Schuetz MJ; Cramer H
    J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glandular cells in vaginal cytology Papanicolaou tests in patients with hysterectomy for endometrial adenocarcinoma.
    Steele E; Umar SA; Bomeisl P; Miedler J; Zanotti KM; Wasman JK; Hunt DC; Abdul-Karim FW
    Diagn Cytopathol; 2012 Feb; 40(2):138-40. PubMed ID: 20891002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
    Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic follow-up in patients with Papanicolaou test findings of endometrial cells: results from a large academic women's hospital laboratory.
    Li Z; Gilbert C; Yang H; Zhao C
    Am J Clin Pathol; 2012 Jul; 138(1):79-84. PubMed ID: 22706861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cells in cervical-vaginal smears of patients treated with tamoxifen.
    Opjorden SL; Caudill JL; Humphrey SK; Salomão DR
    Cancer; 2001 Feb; 93(1):23-8. PubMed ID: 11241262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy.
    Mount SL; Wegner EK; Eltabbakh GH; Olmstead JI; Drejet AE
    Obstet Gynecol; 2002 Sep; 100(3):445-50. PubMed ID: 12220762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
    Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
    Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal endometrial cells in Papanicolaou smears: prevalence in women with and without endometrial disease.
    Gomez-Fernandez CR; Ganjei-Azar P; Behshid K; Averette HE; Nadji M
    Obstet Gynecol; 2000 Dec; 96(6):874-8. PubMed ID: 11084170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic implications of Pap smears classified as atypical glandular cells.
    Haidopoulos DA; Stefanidis K; Rodolakis A; Pilalis A; Symiakaki I; Diakomanolis E
    J Reprod Med; 2005 Jul; 50(7):539-42. PubMed ID: 16130853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cytology in menopausal women at high risk for endometrial disease.
    Van den Bosch T; Vandendael A; Wranz PA; Lombard CJ
    Eur J Cancer Prev; 1998 Apr; 7(2):149-52. PubMed ID: 9818777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of foamy histiocytes in cervical smears from postmenopausal women.
    Kir G; Yilmaz MS; Çetiner H; Gocmen A; Alptekin F
    Acta Cytol; 2014; 58(1):42-6. PubMed ID: 24296692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.